CMS Open Payments · Program Year 2024
CurvaFix, Inc.
CurvaFix, Inc. reported $195,967.34 across General Payments, Research, and Ownership to 135 physicians and teaching hospitals across 136 transactions.
- $196.0K Below-median payer
- All-tracks total
- 136 Below-median volume
- Transactions
- 135 Below-median reach
- Recipients
- +$72.4K
- General Payments vs PY2023
CurvaFix, Inc. reported $195,967.34 across all CMS Open Payments tracks (General + Research + Ownership) to 135 physicians and teaching hospitals in Program Year 2024 - ranking #1005 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $140,597.48, averaging $1.5K per recipient.
How CurvaFix, Inc.'s $196.0K all-tracks total breaks down
CurvaFix, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
21/100
Total payments
F
12/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer curvafix-inc CurvaFix, Inc.
$196.0K · #1005/1,925 · 0.0% industry · PY2024
- TOT $196.0K
- RANK #1005
- SHARE 0.0%
- TXN 136
- RCP 135
- CAT 4
- GEN $140.6K
- ΔGEN +$72.4K
- TOP1 20.7%
- PY 2024
Volume peers
Nearest volume peer: Acuity Surgical Devices, LLC ($196.1K)
CurvaFix, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
CurvaFix, Inc.'s CMS-reported General Payments increased by $72.4K (+106.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CURVAFIX, INC.PY2023: CURVAFIX, INC.PY2024: CurvaFix, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $68,226.01
- PY2024
- $140,597.48
What the Data Shows for CurvaFix, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For CurvaFix, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 4 general-payment categories charted below, "Honoraria" is the largest at $115.2K across 47 transactions, 82.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
CurvaFix, Inc. made 4 types of general payments. "Honoraria" is the largest category at $115.2K, 82.0% of General Payments.
CurvaFix, Inc. reports 4 general-payment categories - the top three are Honoraria (82.0%), Compensation for Services Other Than Consulting (8.8%), and Food and Beverage (5.3%). The remaining 1 category make up 3.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How CurvaFix, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $115.2K | 47 | 82.0% |
| Compensation for Services Other Than Consulting | $12.4K | 10 | 8.8% |
| Food and Beverage | $7.5K | 72 | 5.3% |
| Travel and Lodging | $5.5K | 6 | 3.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $95,570.72 (68.0%) of $140,597.48 in this company's General Payments records across 71 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for CurvaFix, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Samir Mehta
$29,124.43 across 9 reported transactions
- 2
Brett Crist
$20,824.58 across 6 reported transactions
- 3
Karl Van Osten
$18,186.49 across 7 reported transactions
- 4
Milton Routt
$14,396.39 across 5 reported transactions
- 5
Matthew Gardner
$13,038.83 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
CurvaFix, Inc.'s spend rank (#1005 of 1,925, bottom 48% by spend) and concentration rank (#995 of 1,838, bottom 46% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Rigicon,Inc. : $933.53 total payments, HHI 1108
- Monteris Medical Corporation : $197.5K total payments, HHI 1107
- Nuwellis, Inc. : $242.8K total payments, HHI 1104
- GM Pharmaceuticals, Inc. : $1.8K total payments, HHI 1093
- Flower Orthopedics Coporation : $381.4K total payments, HHI 1092
- Metric Medical Devices, Inc. : $10.9K total payments, HHI 1090
- CurvaFix, Inc. (this company) : $140.6K total payments, HHI 1090
- SpringWorks Therapeutics, Inc. : $1.4M total payments, HHI 1087
- Ion Beam Applications S.A. : $32.3K total payments, HHI 1083
- Cumberland Pharmaceuticals, Inc. : $341.4K total payments, HHI 1083
- Cook Incorporated : $6.0M total payments, HHI 1081
- Grifols Shared Services North America, Inc. : $105.0K total payments, HHI 1080
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as CurvaFix, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about CurvaFix, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with CurvaFix, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Haag-Streit USA, Inc.
Vapotherm Inc
Sequence LifeScience, Inc
Pfizer International LLC
Channel Medsystems, Inc.
Put this to use
CurvaFix, Inc. ranks #1005 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just CurvaFix, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.